This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
BrainsWay is ushering in a new era of brain disorder treatment. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression, OCD, and other brain disorders, achieving outcomes not thought possible with traditional medical solutions.
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD
OF POPULATION IS COVERED BY REIMBURSEMENT
Regain your confidence and learn more about BrainsWay’s groundbreaking technology.
Read what patients share about their experience
Does Brainsway’s TMS treatment entail any side effects or risks?
Brainsway® Deep TMS treatment has been proven safe and effective*, and has
How does Brainsway’s TMS treatment compare with ECT?
While ECT entails electrically induced seizures, Brainsway* Deep TMS therapy stimulates brain regions
I have a patient who tried several antidepressants and had poor results – what are the chances of improvement using
What are the CE indications for Brainsway Deep TMS?
Brainsway* has been cleared by the CE for a variety of brain